A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis-Reference-Cited by-同舟云学术

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis

Published:2019-07-25 Issue:1 Volume:17 Page:
ISSN:1546-0096
Container-title:Pediatric Rheumatology
language:en
Short-container-title:Pediatr Rheumatol

Author:

Bava Cecilia^ORCID,Mongelli Federica,Pistorio Angela,Bertamino Marta,Bracciolini Giulia,Dalprà Sara,Davì Sergio,Lanni Stefano,Muratore Valentina,Pederzoli Silvia,Rosina Silvia,Schiappapietra Benedetta,Suffia Chiara,Varnier Giulia,Verazza Sara,Giancane Gabriella,Consolaro Alessandro,Ravelli Angelo

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1186/s12969-019-0355-0.pdf

Reference36 articles.

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767–78.

2. Miller ML, LeBovidge J, Feldman B. Health-related quality of life in children with arthritis. Rheum Dis Clin N Am. 2002;28:493–501.

3. Brunner HI, Giannini EH. Health-related quality of life in children with rheumatic diseases. Curr Opin Rheumatol. 2003;15:602–12.

4. Solari N, Viola S, Pistorio A, Magni-Manzoni S, Vitale R, Ruperto N, et al. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. Arthritis Rheum. 2008;59:1571–9.

5. Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628–34.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Disease Activity in Patients With Juvenile Idiopathic Arthritis at 12 and 24 Months After Diagnosis;ACR Open Rheumatology;2024-06-17

2. Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?;Archives of Rheumatology;2023-08-23

3. Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?;Journal of Clinical Medicine;2022-09-26

4. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis;Arthritis & Rheumatology;2022-03

5. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis;Arthritis Care & Research;2022-03